Home

Jeff L Vacirca

CIK 1724161 · last filed 2026-05-12

Jeff L Vacirca is a corporate insider who has filed 30 SEC Form 4 insider transactions across 4 companies since 2017. The most recent filing shows the insider bought $501.4K of CAI on May 12, 2026. Across all open-market trades the lifetime net is +$1.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.1M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.15M

Companies

4

Total Filings

30

Lifetime Open-Market Net

$1.11M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CAI Director 49,671 $23.14 $1.15M $501.4K 2 2026-05-12
Assertio Holdings, Inc. (ASRT) Delisted Director 10,077 $23.50 $236.8K $11.1K 3 2024-06-12
SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Director 0 $1.03 $0 $22.5K 20 2023-08-01
Odonate Therapeutics, Inc. (ODT) Delisted Director 23,231 $1.12 $26.0K $574.3K 5 2019-06-28

Recent Filings

30 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-05-12 CAI Buy (P) +31,050 $501.4K EDGAR
2026-02-27 CAI Grant (A) +2,492 $50.0K EDGAR
2024-06-12 Assertio Holdings, Inc. (ASRT) Delisted Buy (P) +10,000 $11.1K EDGAR
2024-05-28 Assertio Holdings, Inc. (ASRT) Delisted Grant (A) +53,750 $0 EDGAR
2023-08-02 Assertio Holdings, Inc. (ASRT) Delisted Grant (A) +87,409 $0 EDGAR
2023-08-01 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Disp (D) −295,244 $0 EDGAR
2022-12-02 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Buy (P) +50,000 $22.5K EDGAR
2022-10-27 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Grant (A) +50,000 $21.5K EDGAR
2022-09-02 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Grant (A) +25,000 $0 EDGAR
2022-02-14 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Grant (A) +10,000 $6.8K EDGAR
Showing 1–10 of 30
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.